These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 27766790

  • 21. Real-World Clinical Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist on Mild-to-Moderate Diabetic Kidney Disease in Patients with Type 2 Diabetes: A Retrospective, Single-Arm Clinical Trial.
    Cao Y, Zhao J, Ma Y, Cao S, Liu Y.
    Diabetes Metab Syndr Obes; 2024; 17():2913-2921. PubMed ID: 39108611
    [Abstract] [Full Text] [Related]

  • 22. High concentrations of triglycerides are associated with diabetic kidney disease in new-onset type 2 diabetes in China: Findings from the China Cardiometabolic Disease and Cancer Cohort (4C) Study.
    Gong L, Wang C, Ning G, Wang W, Chen G, Wan Q, Qin G, Yan L, Wang G, Qin Y, Luo Z, Tang X, Huo Y, Hu R, Ye Z, Shi L, Gao Z, Su Q, Mu Y, Zhao J, Chen L, Zeng T, Yu X, Li Q, Shen F, Zhang Y, Wang Y, Deng H, Liu C, Wu S, Yang T, Bi Y, Lu J, Li M, Xu Y, Xu M, Wang T, Zhao Z, Hou X, Chen L.
    Diabetes Obes Metab; 2021 Nov; 23(11):2551-2560. PubMed ID: 34322974
    [Abstract] [Full Text] [Related]

  • 23. Maresin 1 Alleviates Diabetic Kidney Disease via LGR6-Mediated cAMP-SOD2-ROS Pathway.
    Li X, Xu B, Wu J, Pu Y, Wan S, Zeng Y, Wang M, Luo L, Zhang F, Jiang Z, Xu Y.
    Oxid Med Cell Longev; 2022 Nov; 2022():7177889. PubMed ID: 35498124
    [Abstract] [Full Text] [Related]

  • 24. [Change and significance of urinary smad3 in type 2 diabetic nephropathy].
    Guo KF, Kou JX, Lu JX, Zhang L, Yu HY, Chen HB.
    Zhonghua Yi Xue Za Zhi; 2013 Apr 09; 93(14):1067-71. PubMed ID: 23902838
    [Abstract] [Full Text] [Related]

  • 25. The association between thyroid dysfunction (TD) and diabetic kidney disease (DKD) in type 2 diabetes mellitus (T2DM).
    Zheng M, Wang D, Chen L, Chen MN, Wang W, Ye SD.
    Int J Clin Pract; 2019 Sep 11; ():e13415. PubMed ID: 31508877
    [Abstract] [Full Text] [Related]

  • 26. Longitudinal follow-up study of the retrobulbar and intrarenal hemodynamics in patients with T2DM.
    Tai H, Jiang XL, Kuang JS, Yang YF, Song N, Yu JJ, Cui Y, Du Y, Wu Y, Zhang HW, Cui XY, Li N, Zhang LD, Fu X, Jia LQ, Yang GL.
    Medicine (Baltimore); 2019 Nov 11; 98(46):e17792. PubMed ID: 31725621
    [Abstract] [Full Text] [Related]

  • 27. Ethnic disparity in prevalence of diabetic kidney disease in an Asian primary healthcare cluster.
    Loh PT, Toh MP, Molina JA, Vathsala A.
    Nephrology (Carlton); 2015 Mar 11; 20(3):216-23. PubMed ID: 25495003
    [Abstract] [Full Text] [Related]

  • 28. Prevalence of Metabolic Syndrome and Its Risk Factors Influence on Microvascular Complications in Patients With Type 1 and Type 2 Diabetes Mellitus.
    Riaz A, Asghar S, Shahid S, Tanvir H, Ejaz MH, Akram M.
    Cureus; 2024 Mar 11; 16(3):e55478. PubMed ID: 38571859
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of kidney function and risk factors of retinopathy in Type 2 diabetes mellitus people in South Africa.
    Ganjifrockwala FA, Joseph JT, George G.
    Diabetes Res Clin Pract; 2017 May 11; 127():218-223. PubMed ID: 28395215
    [Abstract] [Full Text] [Related]

  • 30. Metformin regulates inflammation and fibrosis in diabetic kidney disease through TNC/TLR4/NF-κB/miR-155-5p inflammatory loop.
    Zhou Y, Ma XY, Han JY, Yang M, Lv C, Shao Y, Wang YL, Kang JY, Wang QY.
    World J Diabetes; 2021 Jan 15; 12(1):19-46. PubMed ID: 33520106
    [Abstract] [Full Text] [Related]

  • 31. C-peptide, glycaemic control, and diabetic complications in type 2 diabetes mellitus: A real-world study.
    Huang Y, Wang Y, Liu C, Zhou Y, Wang X, Cheng B, Kui C, Wang Y.
    Diabetes Metab Res Rev; 2022 May 15; 38(4):e3514. PubMed ID: 34841643
    [Abstract] [Full Text] [Related]

  • 32. [Correlation between weight variability and the risk of diabetic nephropathy in patients with type 2 diabetes mellitus].
    Fang YQ, Wang WW, Liu HH, Tang FL, Yau-Jiunn TJ, Lou QQ.
    Zhonghua Yi Xue Za Zhi; 2024 Mar 12; 104(10):742-750. PubMed ID: 38462354
    [Abstract] [Full Text] [Related]

  • 33. Establishment and Validation of a Risk Prediction Model for Early Diabetic Kidney Disease Based on a Systematic Review and Meta-Analysis of 20 Cohorts.
    Jiang W, Wang J, Shen X, Lu W, Wang Y, Li W, Gao Z, Xu J, Li X, Liu R, Zheng M, Chang B, Li J, Yang J, Chang B.
    Diabetes Care; 2020 Apr 12; 43(4):925-933. PubMed ID: 32198286
    [Abstract] [Full Text] [Related]

  • 34. Diagnostic value of α1-MG and URBP in early diabetic renal impairment.
    Zhou Y, Zhang Y, Chen J, Wang T, Li H, Wu F, Shang J, Zhao Z.
    Front Physiol; 2023 Apr 12; 14():1173982. PubMed ID: 37929213
    [Abstract] [Full Text] [Related]

  • 35. Triglycerides to High-Density Lipoprotein Cholesterol Ratio Predicts Chronic Renal Disease in Patients without Diabetes Mellitus (STELLA Study).
    Raikou VD, Kyriaki D, Gavriil S.
    J Cardiovasc Dev Dis; 2020 Aug 01; 7(3):. PubMed ID: 32752179
    [Abstract] [Full Text] [Related]

  • 36. Correlation between serum miR-154-5p and urinary albumin excretion rates in patients with type 2 diabetes mellitus: a cross-sectional cohort study.
    Ren H, Wu C, Shao Y, Liu S, Zhou Y, Wang Q.
    Front Med; 2020 Oct 01; 14(5):642-650. PubMed ID: 31950345
    [Abstract] [Full Text] [Related]

  • 37. Glomerular filtration Rate, urine Albumin/ creatinine ratio and current perception threshold in patients with diabetic kidney disease.
    Pi CX, Gui TJ, He QD, Yin F, Cai RJ, Wang Y, Xue QX, Tian XK, Wang T, Zhe XW.
    Diabetes Res Clin Pract; 2022 Jul 01; 189():109934. PubMed ID: 35640744
    [Abstract] [Full Text] [Related]

  • 38. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Yamamoto CM, Murakami T, Oakes ML, Mitsuhashi M, Kelly C, Henry RR, Sharma K.
    Am J Nephrol; 2018 Jul 01; 47(5):283-291. PubMed ID: 29779026
    [Abstract] [Full Text] [Related]

  • 39. Serum lutein is a promising biomarker for type 2 diabetes mellitus and diabetic kidney disease in the elderly.
    Pan F, Cui W, Gao L, Shi X, Yang H, Hu Y, Li M.
    J Clin Lab Anal; 2022 Apr 01; 36(4):e24350. PubMed ID: 35293029
    [Abstract] [Full Text] [Related]

  • 40. Discordance in risk factors for the progression of diabetic retinopathy and diabetic nephropathy in patients with type 2 diabetes mellitus.
    Song KH, Jeong JS, Kim MK, Kwon HS, Baek KH, Ko SH, Ahn YB.
    J Diabetes Investig; 2019 May 01; 10(3):745-752. PubMed ID: 30300472
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.